ESSILORLUXOTTICA overview

EssilorLuxottica acquires the Canadian med-tech start-up Cellview The company’s ultra-widefield proprietary technology allows for fast and easy high-quality images, providing a comprehensive view of the retina Paris, France (11 February 2025) – Furthering its commitment to elevating industry standards and enhancing the quality of vision care, EssilorLuxottica has acquired Cellview Imaging Inc, a Canadian start-up specialized in innovative diagnostic via retinal imaging. With the company’s...

EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe Paris, France (3 February 2025) – EssilorLuxottica announced today that it has received clearance from the Food and Drug Administration (FDA) for its OTC Nuance Audio Glasses. The Group has simultaneously achieved the CE marking under the Medical Devices Regulation in the EU, alongside the development of an ISO Quality Management System certification dedicated...

Full-Year 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Full-Year 2024 Results Conference Call on: Wednesday, February 12, 2025, at 6:30 pm CET Dial-in telephone access: If you wish to dial into the conference call, please pre-register at the following...

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (December 11, 2024 - 6:00 pm) – As of November 30, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as...

OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative Paris, France and Geneva, Switzerland (6 December 2024) – The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative. The SPECS initiative builds on the world’s first-ever global target to increase effective refractive...

Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (October 9, 2024 - 6:00 pm) – As of September 30, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks...

Pattern Partners with EssilorLuxottica to Drive Marketplace Business for Ray-Ban and Oakley PR Newswire MELBOURNE, Oct. 7, 2024 MELBOURNE , Oct. 7, 2024 /PRNewswire/ -- The global leader in eyewear design, manufacture and retail, EssilorLuxottica has engaged ecommerce and marketplace accelerator, Pattern , to expand business for its Ray-Ban and Oakley brands through online marketplaces in Australia . "Given the growing influence of marketplaces in Australia , EssilorLuxottica recognised the...

EssilorLuxottica and Meta Announce Long Term Partnership, Shaping the Future of the Smart Eyewear Category Building on the success of Ray-Ban Meta glasses, the two pioneering companies aim to write history of wearables together Paris, France (17 September 2024) – EssilorLuxottica announced today that it has extended its partnership with Meta Platforms by entering into a new long term agreement, under which the parties will collaborate into the next decade to develop multi-generational smart...